Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial 50S ribosomal subunit peptidyl-tRNA site (P-site) is a fundamental component of the bacterial translation machinery, located within the large (50S) ribosomal subunit (Wilson, 2014, Cold Spring Harb Perspect Biol). Its primary biological function is to anchor the tRNA molecule that carries the growing polypeptide chain during the elongation phase of protein synthesis (Poehlsgaard & Douthwaite, 2005, Nat Rev Microbiol). Positioned between the A-site (aminoacyl-tRNA site) and the E-site (exit site), the P-site is integral to the peptidyl transferase center (PTC), where the formation of peptide bonds occurs (StatPearls, 2023). During translation, the nascent peptide is transferred from the P-site tRNA to the incoming amino acid on the A-site tRNA, a process catalyzed by the ribosomal RNA. Because protein synthesis is essential for bacterial survival and growth, the P-site and its surrounding environment are major targets for diverse classes of antibiotics, including oxazolidinones, lincosamides, and pleuromutilins (PubMed, PMID: 25104744). These therapeutic agents work by physically obstructing the P-site or the PTC, thereby halting translation and preventing bacterial replication. Clinical challenges associated with this target include the emergence of resistance through ribosomal mutations or enzymatic modification of the binding site, as well as potential off-target effects on human mitochondrial ribosomes due to structural similarities (NIH, 2022). Understanding the structural nuances of the P-site is vital for overcoming antibiotic resistance mechanisms, such as ribosomal methylation or mutations that prevent drug binding.
Inhibition of bacterial protein synthesis by blocking the peptidyl transferase reaction, preventing the formation of the initiation complex, or obstructing the nascent peptide exit tunnel (StatPearls, 2023; Wilson, 2014).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit peptidyl-tRNA site (P-site) (50S P-site).